Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Quyida tasvirlangan joriy bozor kotirovkalari yangi dori vositalarini ishlab chiqish uchun biotexnologiya inkubatorlari bilan ittifoqlar orqali neyrofarmatsevtikani kengaytirayotgan Eliem Therapeutics (ELYM) moliyaviy holatini tasdiqlaydi. Kompaniyaning rivojlanish dinamikasi bozor bosqichlariga emas, balki klinik sinovlar natijalariga bog'liq. Tibbiyotga bo'lgan barqaror qiziqish ushbu suveren siklni xavfsiz boshpana aktiviga aylantiradi, qaysiki separate_debt_long_eq ko'rsatkichi 0.00 darajasida turibdi.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_ELYM_-_Eliem-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "ELYM - Eliem Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 03.10.2024 oraligʻida | 👁️GURU.Markets👁️")
Eliem Therapeutics, Inc. (ELYM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Eliem Therapeutics|ELYM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Eliem|ELYM - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Eliem Therapeutics Inc.|ELYM - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Eliem Therapeutics|Shoshilinch likvidlik eliemtx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:eliemtx.com
Ushbu koeffitsient uzoq muddatli majburiyatlarning kapitalga nisbatini o'lchab, moliyaviy tuzilmaning barqarorligini aniqlaydi. Investorlar qarz kapitali va moliyaviy mustaqillik o'rtasidagi muvozanatni baholash uchun ushbu hisob-kitobdan foydalanadilar. Uzoq muddatli qarzning kapitalga nisbati dinamikasi haddan tashqari yuqori kredit yuklamasi xatarlarini aniqlashga yordam beradi. Eliem Therapeutics uchun bu noyob komponentlar ta'minot zanjirida uzilishlar yuzaga kelgan taqdirda juda muhimdir. Barqaror koeffitsient geosiyosiy beqarorlik muhitida biotexnologiya biznesining yashab qolishini ta'minlaydi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati harmonybiosciences.com HRMY|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati AMLX (Amylyx Pharmaceuticals Inc)|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Praxis Corp (PRAX)|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Alector|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE (Neurogene Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati ACIU|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Tevogen Bio Inc.|alphacognition.com (ACOG) - Uzoq muddatli qarzning o'z kapitaliga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ABOS: Uzoq muddatli qarzning o'z kapitaliga nisbati|CRVO - Uzoq muddatli qarzning kapitalga nisbati|ATHE (alteritytherapeutics.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLNN: Uzoq muddatli kreditlarning kapitalga nisbati|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|jupiterneurosciences.com (JUNS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio Inc ANVS|Uzoq muddatli qarzning o'z kapitaliga nisbati Grace Therapeutics GRCE|Uzoq muddatli qarzdorlikning kapitalga nisbati Firefly Neuro (AIFF)|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NeuroSense Therapeutics|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA (MetaVia) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NRXS|Uzoq muddatli majburiyatlarning kapitalga nisbati Helius Medical Technologies Inc. HSDT|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati bionomics.com.au NEUP|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|ATHA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Addex Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alzamend Neuro, Inc.|CYCN (cyclerion.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protagenic Therapeutics, Inc. (PTIX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp|CRGT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc (ATXI)|BCLI - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati CARA (Cara Therapeutics, Inc.)|chromocell.com (CHRO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH: Uzoq muddatli qarzning o'z kapitaliga nisbati|MRNS: Uzoq muddatli qarzning kapitalga nisbati|NKGN - Uzoq muddatli qarzdorlikning kapitalga nisbati|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti WENA|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati